Viewing Study NCT00052169

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 10:57 PM
Ignite Modification Date: 2026-05-18 @ 8:01 PM
Study NCT ID: NCT00052169
Status: COMPLETED
Last Update Posted: 2007-12-18
First Post: 2003-01-24
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Therapy With Docetaxel and ZD1839 for Patients Who Have Advanced Breast Cancer
Sponsor: NSABP Foundation Inc
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Breast Neoplasms View
Keywords:

Keywords

Keyword Brief Keyword Text View
None metastatic breast cancer View
None docetaxel View
None Taxotere View
None ZD 1839 View
None gefitinib View
None NSABP View
None advanced breast cancer View
None AstraZeneca View